| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.47▼ | 3.47▼ | 3.47▼ | 3.40▼ | 3.09▲ |
| MA10 | 3.48▼ | 3.47▼ | 3.45▼ | 3.26▼ | 2.86▲ |
| MA20 | 3.40▼ | 3.34▲ | 3.30▲ | 3.08▲ | 2.56▲ |
| MA50 | 3.10▲ | 3.11▲ | 3.11▲ | 2.75▲ | 2.98▲ |
| MA100 | 3.09▲ | 2.94▲ | 2.84▲ | 2.53▲ | 3.40▼ |
| MA200 | 2.71▲ | 2.64▲ | 2.56▲ | 2.98▲ | 3.99▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.017▼ | -0.007▼ | 0.004▲ | 0.006▲ | 0.135▲ |
| RSI | 52.627▲ | 54.142▲ | 55.946▲ | 52.207▲ | 53.575▲ |
| STOCH | 51.364 | 56.655 | 63.884 | 72.632 | 70.057 |
| WILL %R | -92.683▼ | -69.091 | -55.882 | -56.118 | -33.738 |
| CCI | -106.079▼ | -54.714 | -18.421 | 6.431 | 101.302▲ |
|
Thursday, March 12, 2026 10:02 PM
FRAMINGHAM, MA / ACCESS Newswire / March 13, 2026 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
|
|
Thursday, December 11, 2025 02:00 PM
FRAMINGHAM, MA / ACCESS Newswire / December 11, 2025 / Xenetic Biosciences, Inc. (XBIO) (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/04/26 | 3.34 | 3.345 | 3.12 | 3.13 | 8,997 |
| 20/04/26 | 3.50 | 3.52 | 3.30 | 3.40 | 19,449 |
| 17/04/26 | 3.52 | 3.61 | 3.31 | 3.53 | 45,083 |
| 16/04/26 | 3.39 | 3.6799 | 3.3319 | 3.56 | 36,249 |
| 15/04/26 | 3.24 | 3.38 | 3.23 | 3.38 | 6,699 |
| 14/04/26 | 3.18 | 3.267 | 3.15 | 3.26 | 13,339 |
| 13/04/26 | 3.04 | 3.11 | 2.99 | 3.11 | 12,174 |
| 10/04/26 | 3.06 | 3.1847 | 3.0584 | 3.06 | 23,050 |
| 09/04/26 | 3.08 | 3.15 | 3.06 | 3.15 | 12,530 |
| 08/04/26 | 3.29 | 3.29 | 3.05 | 3.05 | 28,829 |
|
|
||||
|
|
||||
|
|